đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
Sexual functional deficiency affects largely the physical conditions, life ...
Status
Unknown
Location
Vinmec Research Institute of Stem Cell and Gene Technology
Start Date
2022-04-01
Trial ID
NCT05345418
Treatments Being Tested
Primary objective: To describe and compare the safety and efficacy of treat...
Status
Completed
Location
Medical University of South Carolina
Start Date
2017-01-11
Trial ID
NCT02947087
Treatments Being Tested
This study will determine the efficacy of High Intensity Laser Therapy (HIL...
Status
Completed
Location
University of RzeszĂłw
Start Date
2018-01-02
Trial ID
NCT03385408
Treatments Being Tested
The primary objective of this study is to investigate the safety and tolera...
Status
Completed
Location
University Hospital
Start Date
2012-06
Trial ID
NCT01624376
The purpose of this study is to assess the safety and tolerability of JNJ-5...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02609789
Treatments Being Tested
Ambroxol is a simple cough medicine that is predicted to slow ALS disease p...
Status
Unknown
Location
Brain and Mind Centre
Start Date
2023-06-13
Trial ID
NCT05959850
Parkinson's disease (PD) is a neurodegenerative disease characterized by th...
Status
Unknown
Location
Multiple Locations
Start Date
2022-05
Trial ID
NCT05355064
Treatments Being Tested
This is a prospective, multi-centre, double blinded, randomized controlled ...
Status
Unknown
Location
University of MĂĄlaga
Start Date
2022-07-01
Trial ID
NCT05305209
Treatments Being Tested
This is a four-site, randomized, parallel design, double-blind, placebo-con...
Status
Completed
Location
Indiana University
Start Date
2013-09-01
Trial ID
NCT02255799
This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-03-28
Trial ID
NCT05622708
Treatments Being Tested